287 related articles for article (PubMed ID: 24180397)
1. Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity.
Pilar-Cúellar F; Vidal R; Díaz A; Castro E; dos Anjos S; Vargas V; Romero B; Valdizán EM
Curr Pharm Des; 2014; 20(23):3776-94. PubMed ID: 24180397
[TBL] [Abstract][Full Text] [Related]
2. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.
Pilar-Cuéllar F; Vidal R; Díaz A; Castro E; dos Anjos S; Pascual-Brazo J; Linge R; Vargas V; Blanco H; Martínez-Villayandre B; Pazos Á; Valdizán EM
Neural Plast; 2013; 2013():537265. PubMed ID: 23862076
[TBL] [Abstract][Full Text] [Related]
3. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
Kim JW; Monteggia LM
Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
[TBL] [Abstract][Full Text] [Related]
4. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.
Masi G; Brovedani P
CNS Drugs; 2011 Nov; 25(11):913-31. PubMed ID: 22054117
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptides in depression: role of VGF.
Thakker-Varia S; Alder J
Behav Brain Res; 2009 Feb; 197(2):262-78. PubMed ID: 18983874
[TBL] [Abstract][Full Text] [Related]
6. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
Quesseveur G; Gardier AM; Guiard BP
Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
[TBL] [Abstract][Full Text] [Related]
7. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.
Castrén E; Rantamäki T
Dev Neurobiol; 2010 Apr; 70(5):289-97. PubMed ID: 20186711
[TBL] [Abstract][Full Text] [Related]
8. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline.
Arakawa S; Shirayama Y; Fujita Y; Ishima T; Horio M; Muneoka K; Iyo M; Hashimoto K
Pharmacol Biochem Behav; 2012 Jan; 100(3):601-6. PubMed ID: 21967886
[TBL] [Abstract][Full Text] [Related]
9. BDNF - a key transducer of antidepressant effects.
Björkholm C; Monteggia LM
Neuropharmacology; 2016 Mar; 102():72-9. PubMed ID: 26519901
[TBL] [Abstract][Full Text] [Related]
10. Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes.
Xu W; Yao X; Zhao F; Zhao H; Cheng Z; Yang W; Cui R; Xu S; Li B
Neural Plast; 2020; 2020():8861903. PubMed ID: 33293948
[TBL] [Abstract][Full Text] [Related]
11. Z-Guggulsterone Produces Antidepressant-Like Effects in Mice through Activation of the BDNF Signaling Pathway.
Liu FG; Hu WF; Wang JL; Wang P; Gong Y; Tong LJ; Jiang B; Zhang W; Qin YB; Chen Z; Yang RR; Huang C
Int J Neuropsychopharmacol; 2017 Jun; 20(6):485-497. PubMed ID: 28339691
[TBL] [Abstract][Full Text] [Related]
12. The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex.
Liu W; Ge T; Leng Y; Pan Z; Fan J; Yang W; Cui R
Neural Plast; 2017; 2017():6871089. PubMed ID: 28246558
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments.
Balu DT; Hodes GE; Anderson BT; Lucki I
Neuropsychopharmacology; 2009 Jun; 34(7):1764-73. PubMed ID: 19177066
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effects of 3,6'-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats.
Hu Y; Liao HB; Dai-Hong G; Liu P; Wang YY; Rahman K
Neurochem Int; 2010 Feb; 56(3):461-5. PubMed ID: 20018220
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response.
Aleksandrova LR; Wang YT; Phillips AG
Neurosci Biobehav Rev; 2019 Oct; 105():1-23. PubMed ID: 31336112
[TBL] [Abstract][Full Text] [Related]
16. [New perspectives of the mechanism of action of antidepressants arised from genomic theory of depression].
Cereseto M; Ferrero A
Vertex; 2003; 14(51):30-5. PubMed ID: 12690407
[TBL] [Abstract][Full Text] [Related]
17. S 47445 counteracts the behavioral manifestations and hippocampal neuroplasticity changes in bulbectomized mice.
Pilar-Cuellar F; Castro E; Bretin S; Mocaer E; Pazos Á; Díaz Á
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():205-213. PubMed ID: 30980840
[TBL] [Abstract][Full Text] [Related]
18. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
Schmidt HD; Duman RS
Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
Sheldrick A; Camara S; Ilieva M; Riederer P; Michel TM
Eur Psychiatry; 2017 Oct; 46():65-71. PubMed ID: 29102768
[TBL] [Abstract][Full Text] [Related]
20. [ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect].
Holtzmann J; Polosan M; Baro P; Bougerol T
Encephale; 2007 Sep; 33(4 Pt 1):572-8. PubMed ID: 18033145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
